1LK3
ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
Summary for 1LK3
| Entry DOI | 10.2210/pdb1lk3/pdb |
| Related | 1J7V |
| Descriptor | Interleukin-10, 9D7 Light Chain, 9D7 Heavy Chain, ... (4 entities in total) |
| Functional Keywords | antigen-antibody complex, immune system |
| Biological source | Homo sapiens (human) More |
| Cellular location | Secreted: P22301 |
| Total number of polymer chains | 6 |
| Total formula weight | 129688.41 |
| Authors | Josephson, K.,Jones, B.C.,Walter, L.J.,DiGiacomo, R.,Indelicato, S.R.,Walter, M.R. (deposition date: 2002-04-23, release date: 2002-07-17, Last modification date: 2024-11-13) |
| Primary citation | Josephson, K.,Jones, B.C.,Walter, L.J.,DiGiacomo, R.,Indelicato, S.R.,Walter, M.R. Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography. Structure, 10:981-987, 2002 Cited by PubMed Abstract: IL-10 is a dimeric cytokine that must engage its high-affinity cell surface receptor, IL-10R1, to induce multiple cellular activities. Here we report the 1.9 A crystal structure of an engineered IL-10 monomer (IL-10M1) in complex with a neutralizing Fab fragment (9D7Fab). 9D7Fab and IL-10R1 bind distinct nonoverlapping surfaces on IL-10M1. Antagonism of the IL-10M1/IL-10R1 interaction is the result of 9D7Fab-induced conformational changes in the CD loop of IL-10M1 that indirectly alter the structure of the IL-10R1 binding site. A single mutation (Ile87Ala) in the same CD loop region of the Epstein-Barr virus IL-10 (ebvIL-10) also reduces IL-10R1 binding affinity, suggesting that ebvIL-10 and 9D7Fab use similar allosteric mechanisms to modulate IL-10R1 affinity and biological activity. PubMed: 12121653DOI: 10.1016/S0969-2126(02)00791-8 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.91 Å) |
Structure validation
Download full validation report






